Anbio Biotechnology Class A Ordinary Shares
HealthcareNASDAQ:NNNN · NASDAQ Global Select
-$0.85 today
Vol 0.03M · Avg 0.03M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
24.0%
avg 46.6%
ROIC
21.6%
avg 44.9%
ROA
23.9%
avg 34.8%
Analysis
ROE is currently the strongest return metric at 24.0% versus its period average of 46.6%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Michael Lau | Chief Executive Officer | $250,000.00 | — | 44 | $0.00 | <0.01% |
Chris Tian | Chief Business Officer | $113,744.00 | — | 35 | $0.00 | <0.01% |
Suki Song | Chief Financial Officer | $100,002.00 | — | 43 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +32.0% | N/A — |
| Revenue | N/A | N/A | -25.4% | N/A — |
| Net Income | N/A | N/A | -10.3% | N/A — |
| EBIT | N/A | N/A | -13.9% | N/A — |
Analysis
Recent growth has been strongest in EPS at +32.0% over three years.
Competitors
Peer companies in the same sector
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
$1.44B
Avanos Medical, Inc.
NYSE:AVNS
$1.17B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
Talkspace, Inc.
NASDAQ:TALK
$872.74M
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
$607.79M
AngioDynamics, Inc.
NASDAQ:ANGO
$499.96M
Community Health Systems, Inc.
NYSE:CYH
$439.66M
ClearPoint Neuro, Inc.
NASDAQ:CLPT
$403.06M
SNDL Inc.
NASDAQ:SNDL
$369.44M
Gossamer Bio, Inc.
GOSS
$38.00M
Who manages NNNN?
Anbio Biotechnology Class A Ordinary Shares (NNNN) lists 3 active executives. The top listed executive is Chris Tian, Chief Business Officer.
Are NNNN insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.